INTERACTION OF SULPIRIDE WITH HUMAN PITUITARY DOPAMINERGIC RECEPTORS IS SODIUM-DEPENDENT

被引:5
作者
SERRI, O
MARCHISIO, AM
SOMMA, M
HARDY, J
COLLU, R
机构
[1] NOTRE DAME HOSP, SERV NEUROSURG, MONTREAL H2L 4K8, QUEBEC, CANADA
[2] UNIV MONTREAL, ST JUSTINE HOSP, NEUROENDOCRINE RES LAB, MONTREAL H3C 3J7, QUEBEC, CANADA
关键词
D O I
10.1159/000179882
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The effects of various drugs on [3H]-spiroperidol binding to human anterior pituitary and prolactinoma membranes are studied in the presence and in the absence of NaCl in the incubation medium. In the absence of NaCl, 1-sulpiride is significantly less potent in displacing the radioactive ligand from its dopaminergic binding sites than in the presence of NaCl. On the contrary, the interaction of neuroleptics (d-butaclamol and haloperidol) and dopamine agonists (apomorphine and bromocriptine) was unaffected by the NaCl conditions.
引用
收藏
页码:153 / 157
页数:5
相关论文
共 16 条
[1]   DOPAMINERGIC RECEPTORS IN HUMAN PROLACTIN-SECRETING ADENOMAS - A QUANTITATIVE STUDY [J].
BRESSION, D ;
BRANDI, AM ;
MARTRES, MP ;
NOUSBAUM, A ;
CESSELIN, F ;
RACADOT, J ;
PEILLON, F .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1980, 51 (05) :1037-1043
[2]  
CARON MG, 1978, J BIOL CHEM, V253, P2244
[3]  
COLLU R, 1983, PROG ENDOCR SOC
[4]   [SPIPERONE-H-3 BINDING TO HUMAN ANTERIOR PITUITARIES AND PITUITARY-ADENOMAS SECRETING PROLACTIN, GROWTH-HORMONE, AND ADRENOCORTICOTROPIC HORMONE [J].
CRONIN, MJ ;
CHEUNG, CY ;
WILSON, CB ;
JAFFE, RB ;
WEINER, RI .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1980, 50 (02) :387-391
[5]   SUBSTITUTED BENZAMIDES - NOVEL CLASS OF DOPAMINE ANTAGONISTS [J].
JENNER, P ;
MARSDEN, CD .
LIFE SCIENCES, 1979, 25 (06) :479-485
[6]  
LOWRY OH, 1951, J BIOL CHEM, V193, P265
[7]   COMPARISON OF THE EFFECTS OF SUBSTITUTED BENZAMIDES AND STANDARD NEUROLEPTICS ON THE BINDING OF H-3-SPIROPERIDOL IN THE RAT PITUITARY AND STRIATUM WITH INVIVO EFFECTS ON RAT PROLACTIN SECRETION [J].
MELTZER, HY ;
SO, R ;
MILLER, RJ ;
FANG, VS .
LIFE SCIENCES, 1979, 25 (07) :573-583
[8]  
MOUREN P, 1970, Semaine des Hopitaux de Paris, V46, P97
[9]   METOCLOPRAMIDE AND DOPAMINE RECEPTOR BLOCKADE [J].
PERINGER, E ;
JENNER, P ;
DONALDSON, IM ;
MARSDEN, CD ;
MILLER, R .
NEUROPHARMACOLOGY, 1976, 15 (08) :463-469
[10]  
PERT CB, 1974, MOL PHARMACOL, V10, P868